two-hundred patients classified to ckd stage 3 or 4 with two separate measurements of hco3- of <21 mmol/l will be 1:1 randomized to either receive a high dose of oral sodium bicarbonate with a serum target hco3- level of 24 ± 1 mmol/l or receive a rescue therapy of sodium bicarbonate with a serum target level of 20 ± 1 mmol/l.